Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverage.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34595947.
- Also identified by DOI 10.18553/jmcp.2021.27.10.1500 and PMC identifier 10390942.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>DISCLOSURES:</b> No funding was received for the writing of this commentary. The authors report no conflicts of interest.
Medical subject headings
- Drug Therapy
- Health Equity
- Lupus Nephritis